News
Ten years after heading to Cannes with Alexander Payne's ‘Nebraska,' Squibb is back with ‘Eleanor the Great’ from director ...
Eleven-year follow-up data continue to show the invasive disease-free survival benefit for node-positive patients seen in previous analyses.
Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple ...
4h
InvestorsHub on MSNPrime Medicine stock plummets amid restructuring and leadership changesShares of Prime Medicine, Inc. (NASDAQ:PRME) fell 19.2% following the company’s announcement of a strategic restructuring ...
The revitalisation of GSK's blood cancer therapy Blenrep has continued with a second regulatory approval, in Japan, as a ...
A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...
19h
MyChesCo on MSNCentury Therapeutics Reports Positive Q1 2025 Results and Advances in Cell Therapy PipelineCentury Therapeutics, Inc. (NASDAQ: IPSC) reported notable progress in Q1 2025, emphasizing advancements in its clinical and preclinical iPSC-derived cell therapy programs. Highlights include updates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results